Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-06-30
1981-05-19
Schafer, Richard E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 422 71, 424 12, G01N 3316, A61K 4300
Patent
active
042684943
ABSTRACT:
Automated radioassay in which a serum is diluted and pre-incubated in the presence of a radioactive labeled ligand, such as an antigen, and a binder, such as an antibody, specific to the ligand. The pre-incubated mixture is flowed through a chamber containing binder specific to the ligand supported on a solid support, and the labeled and unlabeled ligand not bound to the binder in pre-incubation are bound to the receptor on flow through the chamber. An eluting solution is flowed through the chamber to release the ligand bound to the binder in the chamber for reuse thereof. By counting the radioactivity of one or both of the fraction which flows through the chamber or which is subsequently released therefrom the quantity of a specific ligand in the serum may be assayed.
REFERENCES:
patent: 3896217 (1975-07-01), Johnson
patent: 3940475 (1976-02-01), Gross
patent: 3950134 (1976-04-01), Miles
patent: 3950643 (1976-04-01), Charlton
patent: 3989383 (1976-11-01), Paulson
patent: 4009005 (1977-02-01), Johnson
patent: 4022577 (1977-05-01), Brooker
patent: 4108976 (1978-08-01), Reese
Becton Dickinson & Company
Marn Louis E.
Nucker Christine M.
Olstein Elliot M.
Schafer Richard E.
LandOfFree
Automated direct serum radioassay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Automated direct serum radioassay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Automated direct serum radioassay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1489443